SPOKANE, Wash. – Danial Baker, associate dean and professor at the Washington State University College of Pharmacy, has been appointed to a five-year term on the U.S. Pharmacopeial Convention’s Healthcare Quality Expert Committee.
The USP sets the standards that regulate the strength, quality and purity of medicines, food ingredients and dietary supplements manufactured and sold in more than 140 countries. Within the United States, these standards are enforced by the Food and Drug Administration.
“These same principles can then be shared with our student pharmacists at WSU, so they can better understand formulary systems and provide the best quality care for their patients,” said Baker.
He has more than 20 years of experience serving on pharmacy and therapeutics committees involved in making decisions for populations of patients at the regional, state and national level. In October, he was appointed to the U.S. Food and Drug Administration’s Arthritis Advisory Committee. He is director of the WSU Drug Information Center in Spokane.
As one of 25 health care experts on the committee, Baker will create and/or revise the health care quality standards that support the U.S. National Quality Strategy, continuously revise the USP Medicare Model Guidelines and address other public health needs.
The National Quality Strategy, established as part of the Affordable Care Act, is a report to Congress setting guidelines for measuring health care quality and improvement efforts nationwide.
Learn more about Baker at http://www.pharmacy.wsu.edu/facultystaff/bios/baker.d.html and https://archive.news.wsu.edu/2014/10/15/pharmacy-professor-appointed-to-federal-drug-committee/#.VaPN3EY27wA.
Contact:
Lori Maricle, WSU College of Pharmacy communications, 509-368-6679, lmaricle@wsu.edu